S100A8/A9 (Calprotectin), Interleukin-6, and C-Reactive Protein in Obesity and Diabetes before and after Roux-en-Y Gastric Bypass Surgery

Publisher： Karger

E-ISSN： 1662-4033|10|4|386-395

ISSN： 1662-4025

Source： Obesity Facts, Vol.10, Iss.4, 2017-08, pp. : 386-395

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Laparoscopic Roux-en-Y Gastric Bypass Surgery in the Obesity Center Wuerzburg – Patient Selection and Results

By  

Obesity Facts, Vol. 2, Iss. 1, 2009-03 ,pp. : 54-56

Karger

Access to resources Recommend Favorite

What Are Obese Patients Able to Eat after Roux-en-Y Gastric Bypass?

By  

Obesity Facts, Vol. 5, Iss. 3, 2012-06 ,pp. : 339-348

Karger

Access to resources Recommend Favorite

Down-Regulation of Renal Gluconeogenesis in Type II Diabetic Rats Following Roux-en-Y Gastric Bypass Surgery: A Potential Mechanism in Hypoglycemic Effect

By  

Obesity Facts, Vol. 8, Iss. 2, 2015-03 ,pp. : 110-124

Karger

Access to resources Recommend Favorite

Roux-en-Y Gastric Bypass Improves Hepatic Glucose Metabolism Involving Down-Regulation of Protein Tyrosine Phosphatase 1B in Obese Rats

By  

Obesity Facts, Vol. 10, Iss. 3, 2017-06 ,pp. : 191-206

Karger

Access to resources Recommend Favorite

Long-Term (7 Years) Follow-Up of Roux-en-Y Gastric Bypass on Obese Adolescent Patients (<18 Years)

By  

Obesity Facts, Vol. 9, Iss. 2, 2016-04 ,pp. : 91-100

Karger

Access to resources Recommend Favorite